Stock Detail
AMARIN CORPORATION PLC - AMERICAN DEPOSITARY SHARES EACH REPRESENTING ONE ORDINARY SHARE
Biotechnology
AMRN @ Yahoo Finance | AMRN Option @ Yahoo Finance
Last Day's Data
| Current Price | High | Value Change | Percent Change | Dividend | Previous Close |
|---|---|---|---|---|---|
| $7.02 | $7.49 | $-0.18 | -2.50% | 0.00 | $7.20 |
| Opening Price | Low | Volume | Market Cap | Average Volume | P/E |
| $7.39 | $6.97 | 1.88M | 951.22M | 2.61M | -2.75 |
Pivot Table
| R2 | R1 | Pivot | S1 | S2 |
| 7.68 | 7.35 | 7.16 | 6.83 | 6.64 |
Stock Profile
Amarin Corporation plc, a neuroscience pharmaceutical company, engages in the development and commercialization of novel drugs for the treatment of neurological disorders affecting the central nervous system. The company's principal compound, Miraxion, is in phase III development for Huntington's disease. It also develops Miraxion for the treatment of other central nervous system disorders, including treatment unresponsive depression. The company, formerly known as Ethical Holdings plc, was incorporated in 1989 and is headquartered in London.